Anti-CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses
Freshly isolated PBMCs from three healthy volunteers were incubated with a depleting antibody or its isotype control for several hours before being analysed by CITEseq and single cell RNAseq.